Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
TapImmune to Present at World Vaccine & Immunotherapy Congress West Coast | ||
By: PR Newswire Association LLC. - 17 Nov 2017 | Back to overview list |
|
JACKSONVILLE, Fla., Nov. 17, 2017 /PRNewswire/ -- TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced its Chairman and Strategic Advisor Glynn Wilson, Ph.D., and Senior Director of Molecular Biology & Virology Robert Florkiewicz, Ph.D., will give an oral presentation titled, "Increasing the potency of DNA-based immunotherapies using PolyStart™ peptide expression system," at the World Vaccine & Immunotherapy Congress West Coast, held Thursday, November 30 – December 1, 2017, at the Loews Coronado Bay Resort in San Diego, CA. The presentation will highlight data on the Company's proprietary DNA vaccine technology, PolyStart™, and its use in driving DNA vaccine antigen expression and presentation to enable increased visibility of tumor cells to the immune system and more effectively target the cytotoxic activity of CD8+ killer T-cells. Dr. Wilson and Dr. Florkiewicz will be available for one-on-one meetings at the conference. TapImmune Event Details: Title: Increasing the potency of DNA-based immunotherapies using PolyStart™ peptide expression system About TapImmune Inc. For additional information, please call toll free at (904) 862-6490 or visit: tapimmune.com To receive future press releases via email, please visit: https://tapimmune.com/investors/email-alerts/ Follow us on Twitter @Tapimmune_Inc, or follow us on Facebook. Forward-Looking Statement Disclaimer
View original content with multimedia:http://www.prnewswire.com/news-releases/tapimmune-to-present-at-world-vaccine--immunotherapy-congress-west-coast-300558975.html SOURCE TapImmune Inc. |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |